Meet with... The Bill & Melinda Gates Foundation

Add this event to your calendar:
09/04/2015 12:30 09/04/2015 14:30 America/Los_Angeles Meet with... The Bill & Melinda Gates Foundation JLABS , 3210 Merryfield Row , San Diego , CA 92121 JLABS San Diego together with Janssen R&D false DD/MM/YYYY
April
9
Event

Meet with... The Bill & Melinda Gates Foundation

JLABS , 3210 Merryfield Row , San Diego , CA 92121

April 09, 2015 from 12:30 PM to 14:30 PM (PST)

$10 - $35


JLABS SAN DIEGO EVENT This event is sold out and no walkups will be admitted. 

What does it take to save a life? The Bill & Melinda Gates Foundation Global Health Division aims to harness advances in science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools - including vaccines, drugs, and diagnostics - as well as discover path-breaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to those who need them most.

Charlotte Hubbert, Program Investment Officer at the Gates Foundation will be in attendance on April 9th to provide an overview presentation on the Foundation's key areas of interest and best practices when applying for funding. The Gates Foundation has made $3.6 billion in grant payments in 2013 with a total of $31.6 billion in grant payments since its inception.

Charlotte will be on hand to meet with a handful of applicants one-on-one. 

Agenda:
10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ended on March 9th.

Bill & Melinda Gates Foundation Participating Representative:
Charlotte Hubbert | Program Investment Officer, Venture Investing, Bill & Melinda Gates Foundation read bio»

Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until April 8th (or full).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ended on March 9th. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Venue:
JLABS
3210 Merryfield Row
San Diego, CA

Bill & Melinda Gates Foundation Representative's Biography:
Bob More Charlotte Hubbert, Program Investment Officer, Venture Investing, Bill & Melinda Gates Foundation
Charlotte Hubbert is a Program Investment Officer with the Bill & Melinda Gates Foundation focused on Venture Investing for innovative and technologies that support foundation initiatives in Global Health.
Prior to joining the Gates Foundation, Charlotte was a Vice-President at H.I.G. BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics and medical devices at all stages of development. Charlotte started her career in early stage biotech at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing and managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development and management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex. Charlotte currently serves as a member of the Scientific Advisory Board for Oncofactor Corporation.
Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14).

Connect with Charlotte:   Connect on LinkedIn




About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.


JLABS San Diego together with Janssen R&D

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content